Predicting Kinase Inhibitor Resistance: Physics-Based and Data-Driven Approaches

Abstract excerpt

Resistance to small molecule drugs often emerges in cancer cells, viruses, and bacteria as a result of the evolutionary pressure exerted by the therapy. Protein mutations that directly impair drug binding are frequently involved in resistance, and the ability to anticipate these mutations would be beneficial in drug development and clinical practice. Here, we evaluate the ability of three distinct computational...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Drug Discovery Methods
• Share to Monoclonal and Polyclonal Antibodies Research
• Share to Protein Degradation and Inhibitors